Replies to post #385005 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

The enrollment in the Anavex phase 2b/3 trial were not targeted in any way except for early stage Alzheimer’s participants with a baseline MMSE score of greater than or equal to 20.

Good luck and GOD bless,

[ExtremelyBullishZig]

The only problem is that such a small trial has even smaller subgroups which result in hoping the sample size was big enough to consider those subgroups to be reliable. The P2b should really have been the model for P2a.